hareholder Rights Law Firm Johnson Fistel LLP is investigating potential claims against GoodRx Holdings Inc (GoodRx or the Company) (NASDAQ: GDRX) for potential violations of federal securities laws

On September 23 2020 GoodRx sold about 346 million shares of stock in its initial public stock offering (the IPO) at $3300 a share raising approximately $11 billion in new capital Post-IPO GoodRx stock traded at a high of $6422; on December 10 2020 the stock closed at $3892

Specifically Johnson Fistel's investigation seeks to determine whether the Company's filings with the US Securities and Exchange Commission in connection with its September 2020 IPO contained untrue statements of material facts or omitted to state other facts necessary to make the statements made therein not misleading concerning the Company's business and operations

If you have information that could assist in this investigation or if you are a GoodRx shareholder and are interested in learning more about the investigation please contact Jim Baker ([email protected]) at 619-814-4471 If emailing please include a phone number

Additionally you can [Click here to join this action] There is no cost or obligation to you

About Johnson Fistel LLP:
Johnson Fistel LLP is a nationally recognized shareholder rights law firm with offices in California New York and Georgia The firm represents individual and institutional investors in shareholder derivative and securities class action lawsuits For more information about the firm and its attorneys please visit http://wwwjohnsonfistelcom Attorney advertising Past results do not guarantee future outcomes

[Click here to join this action]